secwatch.observer — SEC 8-K summary
======================================

Issuer:     KalVista Pharmaceuticals, Inc. (KALV)
CIK:        0001348911
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001193125-25-227478
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KalVista appoints Bethany Sensenig to Board and Audit Committee; annual meeting results filed
--------------------------------------------------------------------------------

- Bethany Sensenig appointed to Board and Audit Committee effective October 1, 2025.
- Sensenig is CFO and Head of Operations at Radius Health; former Biogen VP of Finance.
- Nancy Stuart moves off Audit Committee but remains on Board and joins Compensation Committee.
- Stockholders re-elected Benjamin Palleiko and Brian Pereira as Class I directors for three-year terms.
- Advisory vote on named executive officer compensation passed with 33.6M shares for vs 4.0M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348911/000119312525227478/0001193125-25-227478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348911/000119312525227478/d945945d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-227478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer